Skip to content
WealthTicker

Compare

NAVs as of 20 Aug 2026

Baroda BNP Paribas Banking and Financial Services FundRegular1 of 4 funds

Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.

Growth of ₹100 (rebased over the selected window)

Common period 25 Jun 201220 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Bank history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.

View as table
Growth of ₹100, sampled across the common period
DateBaroda BNP Paribas Banking and Financial Services Fund
25 Jun 2012₹100.00
30 Aug 2013₹81.92
04 Nov 2014₹150.55
08 Jan 2016₹138.86
14 Mar 2017₹184.52
19 May 2018₹209.79
24 Jul 2019₹231.77
26 Sep 2020₹182.12
01 Dec 2021₹284.92
05 Feb 2023₹307.43
11 Apr 2024₹399.85
15 Jun 2025₹474.97
20 Aug 2026₹502.88
Baroda BNP Paribas Banking and Financial Services Fund compared on return, risk, benchmark-relative, cost and portfolio metrics, against the Sectoral/ Thematic median.
Metric
Baroda BNP Paribas · Regular
NAV ₹50.34
Very High risk
★★☆☆☆
Category median
Sectoral/ Thematic · 252 funds
+4.95%+5.83%
+14.99%+15.63%
+12.79%+13.23%
+11.38%+13.85%
+12.09%+12.26%
+12.86%
+12.40%+15.60%
+11.90%+14.52%
+12.04%+13.74%
Risk
16.36%15.62%
0.520.43
0.720.59
-42.86%-23.65%
Nifty Bank
+4.99%+3.42%
0.900.95
101.0%105.9%
73.1%93.6%
2.68%2.39%
₹395.11Cr₹1,161Cr
1.00%
None
₹500
₹5.00K
47%45%
Yash Mehta · 0.7y
25 Jun 2012
29
59.8%
-1.1%

Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.